BioCentury
ARTICLE | Financial News

Amylin raises $203.1 million in follow-on

March 9, 2012 12:45 AM UTC

Amylin Pharmaceuticals Inc. (NASDAQ:AMLN) raised $203.1 million through the sale of 13 million shares at $15.62 in a follow-on underwritten by Credit Suisse. The company proposed the offering late Wed...